๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX ยท Real-Time Price ยท USD
0.3553
-0.0011 (-0.31%)
At close: Nov 18, 2026, 4:00 PM EST
0.3619
+0.0066 (1.86%)
After-hours: Nov 18, 2026, 7:30 PM EST

Rein Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Profit
------
Operating Income
-22.26-21.93-28.11-15.35-27.65-26.61
Net Income
-49.72-49.87-62.88-15.73-27.33-26.16
Earnings Per Share
-0.93-1.96-3.51-3.42-6.02-5.89
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35.493.2212.8717.3121.2445.93
Total Debt
---0.050.030.16
Net Cash (Debt)
35.493.2212.8717.2721.2145.77
Net Cash Growth
776.80%-75.01%-25.49%-18.60%-53.66%241.12%
Net Cash Per Share
0.660.130.723.754.6710.31

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-22.55-19.36-22.29-19.81-24.87-23.75
Capital Expenditures
------0.16
Free Cash Flow
-22.55-19.36-22.29-19.81-24.87-23.91
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.